Nurse Practitioner, Family · Pascagoula, MS
NPI
1003055617
Since 2009
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
2725 Andrew Ave
Pascagoula, MS, 39567
Phone (228) 762-0713
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
192 services
Medicare patients, 2024
78
Average age 69
Drug cost, 2024
$340K
1,645 prescriptions
Company payments, 2025
$503
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rachel L George was code 99487 (chronic, principal, and transitional care management), 62 times for 15 patients. In total Rachel L George billed 192 services in 13 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99487 Chronic, Principal, and Transitional Care Management | Office | 62 | 15 | $80.48 | $4,990 |
| 90961 ESRD Related Services (not dialysis) | Office | 25 | 20 | $174.53 | $4,363 |
| 90960 ESRD Related Services (not dialysis) | Office | 21 | 12 | $218.03 | $4,579 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 18 | 18 | $99.95 | $1,799 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 15 | 15 | $10.30 | $154 |
| 99214 Office E&M - Established | Office | 13 | 13 | $78.71 | $1,023 |
| 90962 ESRD Related Services (not dialysis) | Office | 12 | 11 | $124.92 | $1,499 |
By year: 2022 $12K for 201 services; 2023 $16K for 235 services; 2024 $20K for 192 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rachel L George prescribed most often to Medicare patients was Prosol (Parenteral Amino Acid 20% No.1), with 201 prescriptions and refills. In total Rachel L George wrote 1,645 Medicare prescriptions that cost $340K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prosol Parenteral Amino Acid 20% No.1 | 201 | 201 | Under 11 | $45K |
| Calcitriol Generic | 163 | 399 | 54 | $2,134 |
| Furosemide Generic | 115 | 279 | 42 | $593 |
| Jardiance Empagliflozin | 112 | 163 | 25 | $93K |
| Farxiga Dapagliflozin Propanediol | 93 | 151 | 22 | $83K |
| Sevelamer Carbonate Generic | 90 | 156 | 29 | $18K |
| Calcium Acetate Generic | 89 | 139 | 34 | $5,538 |
| Amlodipine Besylate Generic | 86 | 221 | 31 | $535 |
| Hydralazine Hcl Generic | 80 | 161 | 29 | $752 |
| Lisinopril Generic | 71 | 171 | 24 | $338 |
| Losartan Potassium Generic | 54 | 140 | 21 | $301 |
| Allopurinol Generic | 47 | 83 | Under 11 | $413 |
| Carvedilol Generic | 36 | 74 | Under 11 | $210 |
| Potassium Chloride Generic | 27 | 75 | 11 | $605 |
| Midodrine Hcl Generic | 24 | 35 | Under 11 | $715 |
Brand drugs: 510 claims; generic drugs: 1,135 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rachel L George $503 ($503 in general payments such as food, travel and fees) from 12 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $97.66.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 5 | $97.66 |
| Vifor Pharma, Inc. | 3 | $87.23 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $63.79 |
| Fresenius USA Marketing, Inc. | 3 | $63.05 |
| Calliditas Therapeutics US Inc. | 2 | $52.12 |
| Ardelyx, Inc. ARDX | 1 | $31.77 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $27.25 |
| Mallinckrodt Hospital Products Inc. | 1 | $25.24 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 1 | $19 |
| OPKO Pharmaceuticals, LLC | 1 | $17.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.